Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check7 days agoChange DetectedThe site revision indicator changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner announces NIH website updates and says the agency is transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check21 days agoChange DetectedThe site revision label in the footer changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check28 days agoChange DetectedThe site revision label in the footer changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error. The full study details are no longer visible, replaced by an error page.SummaryDifference19%

- Check69 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.5 to v3.6.6, indicating a minor site version update with no visible changes to content or study information.SummaryDifference0.1%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.